Cerus
CERS | NASDAQ
$1.86
-$0.13 (-6.30%)
At close: Nov 16, 2026, 4:00 PM ET
$1.86
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-6.30%
(1D)No price chart data available for 1D timeframe.
Rating
52
Fundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #239/1021 (Top 23%)
Key Statistics
Market Data
Market Cap $375.63M
1D Range
1.84 1.97
52W Range
1.49 3.28
Valuation (TTM)
PE -47.94
PB 4.96
EV/EBITDA 494.68
Valuation (NTM)
Forward PE 256.00
Forward PEG 0.78
Price Target $4.00
Cash Flow
FCF Yield 0.1%
SBC Adj. FCF Yield -7.1%
SBC Impact -5475.3%
Margins
Gross Margin 51.8%
Operating Margin -1.1%
FCF Margin 0.2%
Growth (CAGR)
Revenue 3Y | 5Y 13.8% |
13.7%
Dil EPS 3Y | 5Y 45.7% |
38.0%
FCF 3Y | 5Y 167.7% |
62.3%
Returns
ROA -3.6%
ROE -10.5%
ROIC -5.6%
Financial Health
Net Cash
$17M
Current Ratio 1.96
Interest Coverage -1.29
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Cerus Corporation operates as a biotechnology firm dedicated to advancing and marketing the INTERCEPT Blood System. This proprietary technology significantly enhances the safety of transfusable blood ...
Sector Healthcare
Industry Medical - Devices
Employees 268
IPO Date Jan 31, 1997
Website www.cerus.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 2, 2026
EPS
-$0
Beat +78.40%
YoY:
-2600.00% REV
$64M
Beat +1.19%
YoY:
+21.45%Next Earnings
Mar 1, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$4.00
Upside
+115.05%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove CERS